vs
AdvanSix Inc.（ASIX）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
Healthpeak Properties的季度营收约是AdvanSix Inc.的2.0倍（$719.4M vs $359.9M），Healthpeak Properties净利率更高（73.2% vs -0.8%，领先73.9%），AdvanSix Inc.同比增速更快（9.4% vs 3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $36.1M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 3.4%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
ASIX vs DOC — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $719.4M |
| 净利润 | $-2.8M | $114.0M |
| 毛利率 | 7.6% | — |
| 营业利润率 | -0.7% | 17.4% |
| 净利率 | -0.8% | 73.2% |
| 营收同比 | 9.4% | 3.1% |
| 净利润同比 | -892.9% | 2406.4% |
| 每股收益（稀释后） | $-0.11 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $359.9M | $719.4M | ||
| Q3 25 | $374.5M | $705.9M | ||
| Q2 25 | $410.0M | $694.3M | ||
| Q1 25 | $377.8M | $702.9M | ||
| Q4 24 | $329.1M | $698.0M | ||
| Q3 24 | $398.2M | $700.4M | ||
| Q2 24 | $453.5M | $695.5M | ||
| Q1 24 | $336.8M | $606.6M |
| Q4 25 | $-2.8M | $114.0M | ||
| Q3 25 | $-2.6M | $-117.1M | ||
| Q2 25 | $31.4M | $31.7M | ||
| Q1 25 | $23.3M | $42.8M | ||
| Q4 24 | $352.0K | $4.5M | ||
| Q3 24 | $22.3M | $85.9M | ||
| Q2 24 | $38.9M | $146.0M | ||
| Q1 24 | $-17.4M | $6.7M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 58.6% | ||
| Q2 25 | 14.3% | 60.2% | ||
| Q1 25 | 14.2% | 61.1% | ||
| Q4 24 | 3.4% | 60.3% | ||
| Q3 24 | 14.4% | 60.0% | ||
| Q2 24 | 17.9% | 60.6% | ||
| Q1 24 | 0.9% | 59.8% |
| Q4 25 | -0.7% | 17.4% | ||
| Q3 25 | -0.9% | 9.2% | ||
| Q2 25 | 7.7% | 5.7% | ||
| Q1 25 | 7.7% | 7.7% | ||
| Q4 24 | -3.9% | -2.2% | ||
| Q3 24 | 7.5% | 14.1% | ||
| Q2 24 | 11.5% | 22.3% | ||
| Q1 24 | -7.0% | 3.7% |
| Q4 25 | -0.8% | 73.2% | ||
| Q3 25 | -0.7% | -16.6% | ||
| Q2 25 | 7.7% | 4.6% | ||
| Q1 25 | 6.2% | 6.1% | ||
| Q4 24 | 0.1% | 0.7% | ||
| Q3 24 | 5.6% | 12.3% | ||
| Q2 24 | 8.6% | 21.0% | ||
| Q1 24 | -5.2% | 1.1% |
| Q4 25 | $-0.11 | $0.16 | ||
| Q3 25 | $-0.10 | $-0.17 | ||
| Q2 25 | $1.15 | $0.05 | ||
| Q1 25 | $0.86 | $0.06 | ||
| Q4 24 | $0.02 | $0.02 | ||
| Q3 24 | $0.82 | $0.12 | ||
| Q2 24 | $1.43 | $0.21 | ||
| Q1 24 | $-0.65 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $815.2M | $7.5B |
| 总资产 | $1.7B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势，按日历期对齐
| Q4 25 | $19.8M | $467.5M | ||
| Q3 25 | $23.7M | $91.0M | ||
| Q2 25 | $18.4M | $89.4M | ||
| Q1 25 | $8.3M | $70.6M | ||
| Q4 24 | $19.6M | $119.8M | ||
| Q3 24 | $17.3M | $180.4M | ||
| Q2 24 | $12.1M | $106.9M | ||
| Q1 24 | $20.6M | $101.8M |
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
| Q4 25 | $815.2M | $7.5B | ||
| Q3 25 | $818.2M | $7.6B | ||
| Q2 25 | $823.7M | $7.9B | ||
| Q1 25 | $794.4M | $8.2B | ||
| Q4 24 | $774.6M | $8.4B | ||
| Q3 24 | $766.4M | $8.6B | ||
| Q2 24 | $746.6M | $8.8B | ||
| Q1 24 | $713.2M | $8.9B |
| Q4 25 | $1.7B | $20.3B | ||
| Q3 25 | $1.7B | $19.6B | ||
| Q2 25 | $1.6B | $19.8B | ||
| Q1 25 | $1.6B | $19.8B | ||
| Q4 24 | $1.6B | $19.9B | ||
| Q3 24 | $1.5B | $20.0B | ||
| Q2 24 | $1.5B | $20.2B | ||
| Q1 24 | $1.5B | $20.5B |
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $357.0M |
| 自由现金流率自由现金流/营收 | 10.0% | 49.6% |
| 资本支出强度资本支出/营收 | 7.7% | 124.4% |
| 现金转化率经营现金流/净利润 | — | 10.99× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势，按日历期对齐
| Q4 25 | $63.7M | $1.3B | ||
| Q3 25 | $26.6M | $315.0M | ||
| Q2 25 | $21.1M | $363.5M | ||
| Q1 25 | $11.4M | $279.4M | ||
| Q4 24 | $64.2M | $1.1B | ||
| Q3 24 | $57.3M | $318.2M | ||
| Q2 24 | $50.2M | $316.2M | ||
| Q1 24 | $-36.2M | $152.6M |
| Q4 25 | $36.1M | $357.0M | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | — | ||
| Q1 25 | $-22.6M | — | ||
| Q4 24 | $29.8M | $333.7M | ||
| Q3 24 | $26.8M | — | ||
| Q2 24 | $16.7M | — | ||
| Q1 24 | $-71.6M | — |
| Q4 25 | 10.0% | 49.6% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | — | ||
| Q1 25 | -6.0% | — | ||
| Q4 24 | 9.1% | 47.8% | ||
| Q3 24 | 6.7% | — | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | -21.3% | — |
| Q4 25 | 7.7% | 124.4% | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 6.9% | — | ||
| Q1 25 | 9.0% | — | ||
| Q4 24 | 10.4% | 105.6% | ||
| Q3 24 | 7.7% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 10.5% | — |
| Q4 25 | — | 10.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | 11.48× | ||
| Q1 25 | 0.49× | 6.52× | ||
| Q4 24 | 182.29× | 235.43× | ||
| Q3 24 | 2.57× | 3.71× | ||
| Q2 24 | 1.29× | 2.17× | ||
| Q1 24 | — | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
DOC
暂无分部数据
